Breast cancer jab 'prevents the disease in 75% of cases': Treatment could spare thousands of women the trauma of surgery

The main beneficiaries of the jab developed in the U.S. are likely to be women with a very early form of breast cancer called ductal carcinoma in situ, or DCIS.

Read More Home | Mail Online http://www.dailymail.co.uk/home/index.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490

Put the internet to work for you.

via Personal Recipe 420523